These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28771724)

  • 1. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.
    Zare M; Bastami M; Solali S; Alivand MR
    J Cell Physiol; 2018 May; 233(5):3729-3744. PubMed ID: 28771724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
    Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.
    Dugo M; Huang X; Iorio MV; Cataldo A; Tagliabue E; Daidone MG; Wu J; Orlandi R
    Breast; 2018 Jun; 39():46-52. PubMed ID: 29597130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
    Casalino L; Verde P
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
    Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
    J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs Contribute to Breast Cancer Invasiveness.
    Fridrichova I; Zmetakova I
    Cells; 2019 Oct; 8(11):. PubMed ID: 31683635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.
    Yu F; Jiao Y; Zhu Y; Wang Y; Zhu J; Cui X; Liu Y; He Y; Park EY; Zhang H; Lv X; Ma K; Su F; Park JH; Song E
    J Biol Chem; 2012 Jan; 287(1):465-473. PubMed ID: 22074923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
    Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
    Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
    Peng F; Xiong L; Tang H; Peng C; Chen J
    Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro.
    Smolkova B; Miklikova S; Kajabova VH; Babelova A; Yamani NE; Zduriencikova M; Fridrichova I; Zmetakova I; Krivulcik T; Kalinkova L; Matuskova M; Kucerova L; Dusinska M
    Neoplasma; 2016; 63(6):901-910. PubMed ID: 27565328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.